These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 25959521)

  • 1. Remaining hurdles to effective cancer therapy.
    Schaffhausen J
    Trends Pharmacol Sci; 2015 Jun; 36(6):v. PubMed ID: 25959521
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy burden, drug resistance, and optimal treatment regimen for cancer chemotherapy.
    Boldrini JL; Costa MI
    IMA J Math Appl Med Biol; 2000 Mar; 17(1):33-51. PubMed ID: 10757031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roadmap of TRAIL apoptotic pathway-targeted cancer therapies: What is next?
    Bellail AC; Hao C
    Expert Rev Anticancer Ther; 2012 May; 12(5):547-9. PubMed ID: 22594889
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeted toxins.
    Frankel AE; Kreitman RJ; Sausville EA
    Clin Cancer Res; 2000 Feb; 6(2):326-34. PubMed ID: 10690507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calculated resistance in cancer.
    Sawyers CL
    Nat Med; 2005 Aug; 11(8):824-5. PubMed ID: 16079872
    [No Abstract]   [Full Text] [Related]  

  • 6. Bundling next-generation cancer therapies for synergy.
    Kling J
    Nat Biotechnol; 2006 Aug; 24(8):871-2. PubMed ID: 16900109
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics, clinical indications, and resistance mechanisms in molecular targeted therapies in cancer.
    Izar B; Rotow J; Gainor J; Clark J; Chabner B
    Pharmacol Rev; 2013; 65(4):1351-95. PubMed ID: 24092887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of drug sensitivity and resistance in cancer.
    O'Driscoll L
    Curr Cancer Drug Targets; 2009 May; 9(3):250-1. PubMed ID: 19442046
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer and natural selection.
    Fillon M
    J Natl Cancer Inst; 2012 Dec; 104(23):1773-4. PubMed ID: 23213180
    [No Abstract]   [Full Text] [Related]  

  • 10. The phenomenon of multi-drug resistance in the treatment of malignant tumors.
    Vtorushin SV; Khristenko KY; Zavyalova MV; Perelmuter VM; Litviakov NV; Denisov EV; Dulesova AY; Cherdyntseva NV
    Exp Oncol; 2014 Sep; 36(3):144-56. PubMed ID: 25265346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted therapy: overcoming drug resistance with clinical cancer genome.
    Ziogas DE; Katsios CS; Tzaphlidou M; Roukos DH
    Expert Rev Anticancer Ther; 2012 Jul; 12(7):861-4. PubMed ID: 22845399
    [No Abstract]   [Full Text] [Related]  

  • 12. Overcoming multidrug resistance in cancer: 35 years after the discovery of ABCB1.
    Gillet JP; Gottesman MM
    Drug Resist Updat; 2012; 15(1-2):2-4. PubMed ID: 22465109
    [No Abstract]   [Full Text] [Related]  

  • 13. Breakthrough in cancer treatment.
    van der Linde I
    S Afr Med J; 1998 Jul; 88(7):813. PubMed ID: 9698707
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evolution of chemotherapy of cancer. Conceptuals models].
    Lopez M
    Clin Ter; 2000; 151(1):49-55. PubMed ID: 10822882
    [No Abstract]   [Full Text] [Related]  

  • 15. Combining targeted drugs to stop resistant tumors.
    Kaiser J
    Science; 2011 Mar; 331(6024):1542-5. PubMed ID: 21436437
    [No Abstract]   [Full Text] [Related]  

  • 16. Resisting resistance.
    Ewan S
    Drug Discov Today; 2005 Aug; 10(15):1015. PubMed ID: 16055015
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical relevance of P-glycoprotein with respect to the application of resistance modifiers.
    Scheulen ME
    Int J Clin Pharmacol Ther; 1998 Jan; 36(1):41-5. PubMed ID: 9476147
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical cancer research 2001: new agents and therapies.
    Verweij J; de Vries EG
    Drug Resist Updat; 2001 Aug; 4(4):217-23. PubMed ID: 11991676
    [No Abstract]   [Full Text] [Related]  

  • 19. Multidrug resistance reversal agents.
    Robert J; Jarry C
    J Med Chem; 2003 Nov; 46(23):4805-17. PubMed ID: 14584929
    [No Abstract]   [Full Text] [Related]  

  • 20. Preface: National Cancer Act.
    Smalley KS
    Adv Pharmacol; 2012; 65():xi-xiii. PubMed ID: 22959037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.